Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats

Food and Chemical Toxicology

Volumn 50, Issue 11, 2012, Pages 3971-3977

  Radhiga, Thangaiyan ^a   Rajamanickam, Chellam ^b   Senthil, Selvaraj ^a   Pugalendi, Kodukkur Viswanathan ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b Osho Biotech Research Institute   (India)

Author keywords

Atherogenic index; Cardiac markers; DNA damage; Lipid profile; Myocardial infarction; Ursolic acid

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CREATINE KINASE; CREATINE KINASE MB; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 1 ISOENZYME; LACTATE DEHYDROGENASE 2 ISOENZYME; LACTATE DEHYDROGENASE ISOENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; URSOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ASSAY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LIPID ANALYSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ANIMALS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CREATINE KINASE, MB FORM; DNA DAMAGE; HEART; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LIPID METABOLISM; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHOSPHOLIPIDS; RATS; RATS, WISTAR; TRITERPENES;

RATTUS; RATTUS NORVEGICUS;

EID: 84866183396     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.07.067     Document Type: Article

References (47)

1. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974, 20(4):470-475.
2. Balanehru S., Nagarajan B. Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem. Int. 1991, 24(5):981-990.
3. Buring J.E., O' Connor G.T., Goldhaber S.Z., Rosner B., Herbert P.N., Blum C.B., Breslow J.L., Hennekens C.H. Decreased HDL-2 and HDL-3 cholesterol, Apo A-1 and Apo A-II, and increased risk of myocardial infarction. Circulation 1992, 85(1):22-29.
4. Chagoya de Sanchez V., Hernandez-Munoz R., Lopez-Barrera F., Yanez L., Vidrio S., Suarez J., Cota-Garza M.D., Aranda-Fraustro A., Cruz D. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can. J. Physiol. Pharmacol. 1997, 75(12):1300-1311.
5. Chen J.H., Xia Z.H., Tan R.X. High performance liquid chromatographic analysis of bioactive triterpenes in Perilla frutescens. J. Pharm. Biomed. Anal. 2003, 32(6):1175-1179.
6. Coetzee A., Coetzee G. β-Adrenergic blockade during severe ischemia. J. Cardiothorac. Vasc. Anesth. 2002, 16(6):670-678.
7. Cruickshank J.M., Dweyer N.G. β-blocker brain concentration in man. Eur. J. Clin. Pharmacol. 1985, 28:21-23.
8. Deodato B., Altavilla D., Squadrito G., Compo G.M., Arlottan M., MirutoliL L., Saitta A., Cucinotta D., Calapai G., Caputi A.P., Miano M., Squadrito F. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischemia-reperfusion injury. Br. J. Pharmacol. 1999, 128(8):1683-1690.
9. Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertension 2000, 18(6):655-673.
10. Dufour D., Pichette A., Mshvildadze V., Bradette-Herbert M.E., Lavoie S., Longtin A., Laprise C., Legault J. Antioxidant, anti-inflammatory and anticancer activities of methonolic extracts from Ledum groenlanddicum retzius. J. Ethnopharmacol. 2007, 111:22-28.
11. Falholt K., Lund B., Falholt W. An easy colorimetric method for routine determination of free fatty acid in plasma. Clin. Chim. Acta 1973, 46(2):105-111.
12. Folch J., Lees M., Sloane Stanly G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226(1):497-509.
13. Friedwald W.T., Levy R.J., Fredricken D.S. Estimation of VLDL-cholesterol in the plasma without the use of preparative ultracentrifuge. Clin. Chem. 1972, 18(6):449-502.
14. Galvez A.S., Fiedler J.L., Ocaranza M.P., Jalil J.E., Lavandero S., Diaz-Araya G. Perindopril regulates beta-agonist-induced cardiac apoptosis. J. Cardiovasc. Pharmacol. 2005, 46(3):255-261.
15. Gesquiere L., Loreau N., Minnich A., Davignon J., Blache D. Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic. Biol. Med. 1999, 27(1-2):134-145.
16. Han S.K., Ko Y.I., Park S.J., Jin I.J., Kim J.M. Oleanolic acid and ursolic acid stabilize liposomal membranes. Lipids 1997, 32(7):769-773.
17. Harmand P.O., Duval R., Delage C., Simon A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int. J. Cancer 2005, 114(1):1-11.
18. Izzo C., Grillo F., Murador E. Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin. Chem. 1981, 27(3):371-374.
19. Joshi C.N., Jain S.K., Murthy P.S. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res. Protoc. 2004, 13(1):11-17.
20. Khalid M.A., Ashraf M. Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation. Is the hydroxyl radical really the most damaging radical species?. Circ. Res. 1993, 72(4):725-736.
21. Gürgün C., Ildizli M., Yavuzgil O., Sin A., Apaydin A., Cinar C., Kültürsay H. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure. Int. J. Cardiol. 2008, 123(2):102-107.
22. Levinson S.S., Hobbs G.A. Usefulness of various lactate dehydrogenase isoenzyme 1 profiles after myocardial infarction. Ann. Clin. Lab Sci. 1994, 24(4):364-370.
23. Lie J.T., Pariolero P.C., Holley K.E., Titus J.L. Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J. Thorac. Cardiovasc. Surg. 1975, 69(4):599-605.
24. Liu J. Pharmacology of oleanolic acid and ursolic acid. J. Ethanopharmacol. 1995, 49(2):57-68.
25. Liu J. Oleanolic acid and ursolic acid: research perspectives. J. Ethanopharmacol. 2005, 100(1-2):92-94.
26. Lu J., Zheng Y.L., Wu D.M., Luo L., Sun D.X., Shan Q. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose. Biochem. Pharmacol. 2007, 74(7):1078-1090.
27. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983, 29(3):538-542.
28. McKenzie D., Henderson A.R. Electrophoresis of lactate dehydrogenase isoenzymes. Clin. Chem. 1983, 29(1):189-195.
29. Mehta K., Balaraman R., Amin A.H., Bafna P.A., Gulati O.D. Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits. J. Ethnopharmacol. 2003, 86(2-3):191-195.
30. Militante J.D., Lombardini J.B. Dietary taurine supplementation: hypolipidemic and antiatherogenic effects. Nutr. Res. 2004, 24:787-801.
31. Mohanty I., Arya D.S., Dinda A., Talwar K.K., Joshi S., Gupta S.K. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin. Pharmacol. Toxicol. 2004, 94:184-190.
32. Morimoto C., Kiyama A., Kameda K., Ninomiya H., Tsujita T., Okuda H. Mechanism of the stimulatory action of okadaic acid on lipolysis in rat fat cells. J. Lipid Res. 2000, 41(2):199-204.
33. Mortin-Aragon S., De Las Heras B., Sanchez-Reus M.I., Benedi J. Pharmocological modification of endogenous antioxidative enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rats hepatocytes. Exp. Toxicol. Pathol. 2001, 53(2-3):199-206.
34. Osadchii O.E., Norton G.R., McKechnie R., Deftereos D., Woodiwiss A.J. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Am. J. Physiol. Heart Circ. Physiol. 2007, 292(4):1898-1905.
35. Ovesna Z., Kozics K., Slamenova D. Protective effects of ursolic acid and oleanolic acid in leukemic cells. Mutat. Res. 2006, 600(1-2):131-137.
36. Sandritter W., Jestadt R. Triphenyltetrazolium chloride (TTC) als reduktion-indikator zur makroskopischen diagnose des frischen herzinfarktes. Verk. Dtsch. Ges. Pathol. 1958, 41:165-177.
37. Saravanan R., Viswanathan P., Pugalendi K.V. Protective effect of ursolic acid on ethanol mediated experimental liver damages in rats. Life Sci. 2006, 78(7):713-718.
38. Seth S.D., Maulik M., Katiyar C.K., Maulik S.K. Role of lipistat in protection against isoproterenol-induced myocardial necrosis in rats: a biochemical and histopathological study. Indian J. Physiol. Pharmacol. 1998, 42(1):101-106.
39. Shih Y.H., Chein Y.C., Wang J.Y., Fu Y.S. Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats. Neurosci. Lett. 2004, 362(2):136-140.
40. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175(1):184-191.
41. Slater A.M., White D.A. Effect of dietary fat on cholesterol metabolism. Regulation of plasma LDL concentrations. Nutr. Res. Rev. 1996, 9(1):241-257.
42. Somova L.I., Shode F.O., Mipando M. Cardiotonic and antidysrhythmic effects of oleanolic acid and ursolic acids, methyl maslinate and uvaol. Phytomedicine 2004, 11(2-3):121-129.
43. Van der Heide R.S., Rim D., Hohl C.M., Ganote C.E. An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J. Mol. Cell Cardiol. 1990, 22(2):165-181.
44. Voet J.G., Donald V. ATP driven active transport, Textbook of Biochemistry 1995, John Wiley, New York, pp. 524-535. second ed.
45. Wang B.H., Polya G.M. Selective inhibition of cyclic AMP dependent protein kinase by amphypylic triterpenoids and related compounds. Phytochemistry 1996, 41(1):55-63.
46. Zhou R., Xu Q., Zheng P., Yan L., Zheng J., Dai G. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur. J. Pharmacol. 2008, 586(1-3):244-250.
47. Zilversmit D.B., Davis A.K. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J. Lab. Clin. Med. 1950, 35(1):155-160.